The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Effects of Estrogen plus Progestin on Health-Related Quality of Life
Open accessAbstract
BACKGROUND: The Women's Health Initiative (WHI) and other clinical trials indicate that significant health risks are associated with combination hormone use. Less is known about the effect of hormone therapy on health-related quality of life. METHODS: The WHI randomly assigned 16,608 postmenopausal women 50 to 79 years of age (mean, 63) with an intact uterus at base line to estrogen plus progestin (0.625 mg of conjugated equine estrogen plus 2.5 mg of medroxyprogesterone acetate, in 8506 women) or placebo (in 8102 women). Quality-of-life measures were collected at base line and at one year in all women and at three years in a subgroup of 1511 women. RESULTS: Randomization to estrogen plus progestin resulted in no significant effects on general health, vitality, mental health, depressive symptoms, or sexual satisfaction. The use of estrogen plus progestin was associated with a statistically significant but small and not clinically meaningful benefit in terms of sleep disturbance, physical functioning, and bodily pain after one year (the mean benefit in terms of sleep disturbance was 0.4 point on a 20-point scale, in terms of physical functioning 0.8 point on a 100-point scale, and in terms of pain 1.9 points on a 100-point scale). At three years, there were no significant benefits in terms of any quality-of-life outcomes. Among women 50 to 54 years of age with moderate-to-severe vasomotor symptoms at base line, estrogen and progestin improved vasomotor symptoms and resulted in a small benefit in terms of sleep disturbance but no benefit in terms of the other quality-of-life outcomes. CONCLUSIONS: In this trial in postmenopausal women, estrogen plus progestin did not have a clinically meaningful effect on health-related quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although several studies comparing HT to a placebo have found that HT improves perceived sleep quality and self-reported sleeping problems more than a placebo [112-123]”
From Non-Pharmacological Treatment of Insomnia (2012) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
Robins, L. N. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780290015001 · Cited by 5,219
The rand 36‐item health survey 1.0
Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993) · Health Economics · doi:10.1002/hec.4730020305 · Cited by 2,971
(1987) · PubMed · Cited by 2,657
Design of the Women’s Health Initiative Clinical Trial and Observational Study
The Women’s Health Initiative Study Group (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,580
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
Grady, D. G., Herrington, D. M., Bittner, V., Blumenthal, R. S., Davidson, M., Hlatky, M. A., Hsia, J. A., Hulley, S. B., Herd, A. J., Khan, S. S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,921
Parametric measures of effect size.
Rosenthal, R. (1994) · Cited by 1,856
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Self-citationEstrogen Deficiency and Risk of Alzheimer's Disease in Women
Paganini‐Hill, A., & Henderson, V. W. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117244 · Cited by 850
Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women
Judd, H. L. (1996) · JAMA · doi:10.1001/jama.1996.03530290040035 · Cited by 605
Oestrogen Therapy and the Menopausal Syndrome
Campbell, S. C., & Whitehead, M. I. (1977) · Clinics in Obstetrics and Gynaecology · doi:10.1016/s0306-3356(21)00374-5 · Cited by 542
Development of a Brief Screening Instrument for Detecting Depressive Disorders
Burnam, M. A., Wells, K. B., LEAKE, B. D., & Landsverk, J. L. (1988) · Medical Care · doi:10.1097/00005650-198808000-00004 · Cited by 501
The Concept of Clinically Meaningful Difference in Health-Related Quality of Life Research
Hays, R. D., & Woolley, J. M. (2000) · PharmacoEconomics · doi:10.2165/00019053-200018050-00001 · Cited by 492
Estrogen Replacement Therapy and Cognitive Function in Older Women
Barrett-Connor, E. L. (1993) · JAMA · doi:10.1001/jama.1993.03500200051032 · Cited by 377
A meta-analysis of the effect of hormone replacement therapy upon depressed mood
Zweifel, J. E., & O'Brien, W. H. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00034-0 · Cited by 330
Greendale, G. A. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00305-6 · Cited by 314
Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy
Hlatky, M. A., Boothroyd, D. B., Vittinghoff, E., Sharp, P. C., & Whooley, M. A. (2002) · JAMA · doi:10.1001/jama.287.5.591 · Cited by 302
Shah, M., & Maïbach, H. I. (2001) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200102030-00003 · Cited by 220
Menopausal Symptoms in Older Women and the Effects of Treatment With Hormone Therapy
Barnabei, V. M., Grady, D., Stovall, D. W., Cauley, J. A., Lin, F., Stuenkel, C. A., Stefanick, M. L., & Pickar, J. H. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02369-4 · Cited by 165
Effects of estrogen replacement on the progression of coronary artery atherosclerosis
Herrington, D. M., Beboussin, D. M., & Brosnihan, K. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(00)00172-0 · Cited by 151
Factor structure and measurement invariance of the Women's Health Initiative Insomnia Rating Scale.
Levine, D. W., Kaplan, R. M., Kripke, D. F., Bowen, D. J., Naughton, M. J., & Shumaker, S. A. (2003) · Psychological Assessment · doi:10.1037/1040-3590.15.2.123 · Cited by 150
U.S. Preventive Services Task Force* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00013 · Cited by 144
Women's Health Initiative: Why now? What is it? What's new?
Matthews, K. A., Shumaker, S. A., Bowen, D. J., Langer, R. D., Hunt, J. R., Kaplan, R. M., Klesges, R. C., & Ritenbaugh, C. (1997) · American Psychologist · doi:10.1037/0003-066x.52.2.101 · Cited by 127
m, K. R. D., Bengtsson, C., Lissner, L., Milsom, I., Sundh, V., & Bj�rkelund, C. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200205000-00003 · Cited by 122
Effects of Hormone Replacement Therapy on Sexual Psychophysiology and Behavior in Postmenopause
Sarrel, P. M. (2000) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460900318830 · Cited by 109
The impact of hormone replacement therapy on quality of life and willingness to pay
Zethraeus, N., Johannesson, M., Henriksson, P., & Strand, R. T. (1997) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb10945.x · Cited by 90
Surveying Physicians To Determine the Minimal Important Difference
van Walraven, C., Mahon, J. L., Moher, D., Bohm, C. J., & Laupacis, A. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00050-5 · Cited by 73
Estrogen replacement therapy and cognitive function in older women
Barrett-Connor, E. L. (1993) · JAMA · doi:10.1001/jama.269.20.2637 · Cited by 72
Girdler, S. S., O'BRIANT, C., Steege, J. F., Grewen, K., & Light, K. C. (1999) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/jwh.1.1999.8.637 · Cited by 49
Menopausal women as decision makers in health care
Rothert, M. L., Padonu, G., Holmes-Rovner, M. M., Kroll, J., Talarczyk, G., Rovner, D. R., Schmitt, N., & Breer, L. (1994) · Experimental Gerontology · doi:10.1016/0531-5565(94)90026-4 · Cited by 38
Flagged first, then by citations
Research works printed but not linked: 2
- FDA approves new labels for estrogen and estrogen with progestin therapies for postmenopausal women following review of Women's Health Initiative data. Rockville, Md.: Food and Drug Administration, January 8, 2003.
- Teng EL, 1987, J Clin Psychiatry, 48, 314
Cited by
Sorted by citations
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C. C., Rizzoli, R., & Reginster, J. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,993
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M. L. S., Lane, D. S., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,871
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Conrad, P. (2007) · Johns Hopkins University Press eBooks · doi:10.56021/9780801885846 · Cited by 1,448
Metadata
- Authors
- Hays, J., Ockene, J. K., Brunner, R. L., Kotchen, J. M., Manson, J. E., Patterson, R. E., Aragaki, A. K., Shumaker, S. A., Brzyski, R. G., LaCroix, A. Z., Granek, I. A., & Valanis, B. G.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- University of Nevada, Reno (US)
- Medical College of Wisconsin (US)
- Brigham and Women's Hospital (US)
- Fred Hutch Cancer Center (US)
- Wake Forest University Health Sciences (US)
- The University of Texas at San Antonio Health Science Center (US)
- State University of New York (US)
- Kaiser Permanente Center for Health Research (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05-08
- Volume
- 348
- Issue
- 19
- Pages
- 1839-1854
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2110502449
- Cited by
- 686
- References
- 36
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 11 · 2018: 12 · 2017: 9 · 2016: 17 · 2015: 15 · 2014: 18 · 2013: 23 · 2012: 25
- FWCI
- 66.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- estrogen plus progestin, hormone therapy, health-related quality of life, postmenopausal women, conjugated equine estrogens, medroxyprogesterone acetate, vasomotor symptoms, sleep disorders, physical function, bodily pain, depressive symptoms, sexual satisfaction, Women's Health Initiative
- MeSH terms
- Aged, Cognition, Depression, Estrogens, Female, Health Status, Humans, Mental Health, Middle Aged, Progestins, Quality of Life, Sexual Behavior, Sleep Wake Disorders, Estrogen Replacement Therapy, Linear Models, Hot Flashes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
